
doi: 10.5070/d30d70k7b2
pmid: 22398230
Photosensitivity to sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is reported. No previous reports of photosensitivity to any DPP-4 inhibitors are known. Physical examination of the patient revealed edematous plaques confined to sun-exposed areas of the skin. An unusual finding in this case was the spongy sensation upon palpation of the plaques. Histopathology revealed parakeratosis and abundant eosinophils, supporting the clinical impression of cutaneous drug sensitivity. The eruption finally cleared, approximately two years after onset.
Male, Dipeptidyl-Peptidase IV Inhibitors, Sitagliptin Phosphate, Triazoles, Treatment Outcome, Diabetes Mellitus, Type 2, Protective Clothing, Pyrazines, Humans, Hypoglycemic Agents, Photosensitivity Disorders, Aged
Male, Dipeptidyl-Peptidase IV Inhibitors, Sitagliptin Phosphate, Triazoles, Treatment Outcome, Diabetes Mellitus, Type 2, Protective Clothing, Pyrazines, Humans, Hypoglycemic Agents, Photosensitivity Disorders, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 16 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
